Tracked deals
11
11 tracked deals across 2021-2025.
Private Equity Firm
Healthcare
Gyrus Capital
Geneva, Geneva, Switzerland
Gyrus Capital is a Geneva-based private equity firm focused on transformational healthcare investments, supporting management to drive change and unlock value.
- Focus Areas
- Healthcare services, Medical technology / medical devices
- Website
- www.gyruscapital.com
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Buyout
4 buyout · 3 growth capital · 2 addon
Gyrus Capital Acquisition Volume by Year
Last 5 years
Supporting Data
Recent Transactions
-
April 17, 2025
- Buyer
- Gyrus Capital
- Target
- ACBC (Anything Can Be Changed)
- Industry
- Consulting
- Location
- Lombardy, Italy
- Type
- Buyout
Gyrus Capital, a European investment firm, will acquire a majority stake in ACBC (Anything Can Be Changed), a Milan-based B Corp specializing in sustainable fashion R&D, product innovation and circular solutions. The investment will support ACBC's international expansion, service diversification and targeted acquisitions while the co-founders and management reinvest and remain involved.
-
September 17, 2024
- Buyer
- Gyrus Capital SA, Swisscom Ventures, Verve Ventures, 4FO (4FO Ventures), Credit Suisse Entrepreneur Capital, Vincent Lefauconnier, Jonas Larsson
- Target
- Neo Medical SA
- Industry
- Medical Devices
- Location
- Vaud, Switzerland
- Type
- Growth capital
Swiss private equity firm Gyrus Capital led a strategic equity investment of up to $68 million (CHF 58 million) into Swiss medical-technology company Neo Medical SA, with participation from existing investors including Swisscom Ventures, Verve Ventures, 4FO and Credit Suisse Entrepreneur Capital as well as the founders. The financing will fund Neo Medical’s US expansion, deployment of new spine surgery products, and further development of its AI-driven augmented reality intraoperative platform ADVISE.
-
April 17, 2024
- Buyer
- Homnya, Consulcesi Group, Gyrus Capital
- Target
- Editoriale Giornalidea
- Seller
- Editoriale Giornalidea shareholders (Verlato family)
- Industry
- Media & Entertainment
- Location
- Lombardy, Italy
- Type
- Buyout
Homnya, the healthcare data-marketing media company within the Consulcesi Group, has acquired Editoriale Giornalidea, a long-established Italian publisher serving pharmacists (titles include Farma 7, Farma Mese and Panorama Cosmetico) and digital outlets such as Pharmacy Scanner. The deal expands Homnya's pharmacy-focused media and data capabilities and aims to create the largest community of pharmacists in Italy by combining Giornalidea's assets with Homnya's SICS and Quotidiano Sanità businesses.
-
August 1, 2023
- Buyer
- Gyrus Capital
- Target
- LRE Medical
- Seller
- AIS Global, KPS Capital Partners
- Industry
- Medical Devices
- Location
- Bavaria, Germany
- Type
- Buyout
Gyrus Capital, a Geneva-based investment firm, has acquired LRE Medical, a Germany-headquartered maker of complex diagnostic devices and analytical instruments, from AIS Global (previously a KPS-backed business). LRE Medical (founded 1961) operates two sites in Germany with more than 250 employees; the transaction—a carve-out/buyout—closed in August 2023 and is intended to accelerate growth in point-of-care diagnostics.
-
- Buyer
- Essential Pharma, Gyrus Capital
- Target
- HALDOL (haloperidol), HALDOL Decanoate (haloperidol decanoate)
- Seller
- Janssen Pharmaceutica NV
- Industry
- Pharmaceuticals
- Location
- Antwerp, Belgium
- Type
- Divestiture
Gyrus Capital-backed Essential Pharma has acquired global rights to HALDOL (haloperidol) and HALDOL Decanoate from Janssen Pharmaceutica NV. The deal expands Essential Pharma's specialty CNS portfolio and secures continued global supply of this WHO-listed essential antipsychotic marketed in the US and more than 60 countries.
-
December 1, 2022
- Buyer
- Gyrus Capital, Massimo Tortorella and Consulcesi management (co-investors)
- Target
- Consulcesi Group
- Industry
- Healthcare Services
- Location
- Ticino, Switzerland
- Type
- Growth capital
Funds advised by Gyrus Capital have acquired a 40% stake in Consulcesi Group, with founder Massimo Tortorella and management remaining involved. The investment will support Consulcesi's international expansion and M&A-driven growth to build a pan‑European digital healthcare platform and target doubling revenue to over €120 million by 2025.
-
June 24, 2022
- Buyer
- Gyrus Capital
- Target
- Katalist Group
- Industry
- IT Services
- Type
- Buyout
Gyrus Capital has agreed with Katalist Group founders and management to acquire a majority stake in Katalist Group to build a global software integration platform serving food wholesalers/retailers and pharmacy companies. Katalist — a software implementation and consulting specialist with more than 300 employees operating across Europe, Asia and the Americas — will pursue growth through further acquisitions and integration of specialist software implementors.
-
December 23, 2021
- Buyer
- Hayfin Capital Management LLP, Gyrus Capital
- Target
- Corcym
- Industry
- Medical Devices
- Location
- England, United Kingdom
- Type
- Growth capital
Corcym, a global medical device company focused on structural heart solutions, closed a €45 million growth financing arranged by funds managed by Hayfin Capital Management. The financing (preferred equity plus a senior credit facility) will support Corcym's international expansion and strategic growth initiatives alongside existing investor Gyrus Capital.
-
October 1, 2021
- Buyer
- DuPont Sustainable Solutions, Gyrus Capital
- Target
- Sofies Group
- Industry
- Consulting
- Location
- Geneva, Switzerland
- Type
- Addon
Gyrus Capital-backed DuPont Sustainable Solutions (DSS) has acquired Sofies Group, a global sustainability project management and consulting firm. The acquisition adds Sofies’ sustainability IP, methodologies and consulting team to DSS as an add-on to expand DSS’s ESG and sustainability capabilities across public and private clients.
-
- Buyer
- DuPont Sustainable Solutions (DSS), Gyrus Capital
- Target
- KKS Advisors
- Industry
- Consulting
- Location
- England, United Kingdom
- Type
- Addon
Gyrus Capital-backed DuPont Sustainable Solutions (DSS) has acquired KKS Advisors, a global ESG and sustainability consulting firm, effective June 30, 2021. The acquisition brings KKS's ESG IP, methodologies and senior team into DSS, expanding DSS's sustainability, strategy and ESG advisory capabilities and creating a more integrated operations-to-sustainability offering.
-
June 4, 2021
- Buyer
- Gyrus Capital, Management team of the PwC Italia consulting business (co-investors)
- Target
- PwC Italia consulting business (Public Administration and Public Healthcare consulting)
- Seller
- PwC Italia
- Industry
- Consulting
- Location
- Italy
- Type
- Divestiture
Gyrus Capital has agreed to acquire PwC Italia's consulting business that advises public administration and public healthcare systems on transformation, technology and project management. The carve-out—employing about 700 people—will be rebranded and remain led by the current management team, which will co-invest alongside Gyrus; the transaction was expected to close in Q3 2021. Gyrus intends to expand the team and product offering in Italy and internationally.
Related Acquisition Pages
Selling a company? Get in front of buyers like Gyrus Capital
Turn tracked acquisition activity into an outreach-ready buyer list.